ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
15.57
+0.39 (2.57%)
At close: Feb 27, 2026, 4:00 PM EST
15.28
-0.29 (-1.86%)
After-hours: Feb 27, 2026, 7:45 PM EST
ADMA Biologics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 146.93 | 197.67 | -28.24 | -65.9 | -71.65 | Upgrade
|
| Depreciation & Amortization | 8.1 | 8.05 | 8.33 | 7.11 | 5.5 | Upgrade
|
| Other Amortization | 0.72 | 0.95 | 2.59 | 2.4 | 1.9 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | 0.11 | 0.18 | 0.43 | 0.22 | Upgrade
|
| Stock-Based Compensation | 20.03 | 13.62 | 6.19 | 5.22 | 3.49 | Upgrade
|
| Other Operating Activities | 14.21 | -83.18 | 29.87 | 9.53 | -0.14 | Upgrade
|
| Change in Accounts Receivable | -108.43 | -22.58 | -11.92 | 13.07 | -15.34 | Upgrade
|
| Change in Inventory | -36.23 | 2.67 | -9.63 | -38.56 | -43.19 | Upgrade
|
| Change in Accounts Payable | 2.33 | 4.15 | 3.84 | 0.8 | 1.36 | Upgrade
|
| Change in Other Net Operating Assets | 2.74 | -2.78 | 7.58 | 6.4 | 5.49 | Upgrade
|
| Operating Cash Flow | 50.4 | 118.67 | 8.8 | -59.51 | -112.37 | Upgrade
|
| Operating Cash Flow Growth | -57.53% | 1248.55% | - | - | - | Upgrade
|
| Capital Expenditures | -22.58 | -8.23 | -4.77 | -13.91 | -13.51 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.32 | -0.35 | -0.21 | - | - | Upgrade
|
| Other Investing Activities | 1 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -21.89 | -8.58 | -4.98 | -13.91 | -13.51 | Upgrade
|
| Long-Term Debt Issued | 105 | - | 135 | 151.75 | - | Upgrade
|
| Long-Term Debt Repaid | -105.94 | -60 | -158.6 | -100.04 | -0.03 | Upgrade
|
| Net Debt Issued (Repaid) | -0.94 | -60 | -23.6 | 51.71 | -0.03 | Upgrade
|
| Issuance of Common Stock | 2.98 | 7.49 | 1.1 | 64.82 | 121.14 | Upgrade
|
| Repurchase of Common Stock | -41.49 | -4.97 | -1.42 | -2.9 | -0.06 | Upgrade
|
| Other Financing Activities | -4.58 | -0.83 | -15.08 | -4.78 | - | Upgrade
|
| Financing Cash Flow | -44.02 | -58.3 | -38.99 | 108.85 | 121.05 | Upgrade
|
| Net Cash Flow | -15.52 | 51.8 | -35.17 | 35.43 | -4.83 | Upgrade
|
| Free Cash Flow | 27.82 | 110.45 | 4.03 | -73.42 | -125.88 | Upgrade
|
| Free Cash Flow Growth | -74.81% | 2641.28% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 5.45% | 25.90% | 1.56% | -47.65% | -155.52% | Upgrade
|
| Free Cash Flow Per Share | 0.11 | 0.47 | 0.02 | -0.37 | -0.90 | Upgrade
|
| Cash Interest Paid | 9.08 | 10.67 | 18.05 | 13.88 | 11.16 | Upgrade
|
| Cash Income Tax Paid | 19.68 | 9.39 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -18.15 | 75.16 | -0.93 | -53.5 | -96.39 | Upgrade
|
| Unlevered Free Cash Flow | -14.43 | 82.91 | 12.11 | -43.85 | -90.13 | Upgrade
|
| Change in Working Capital | -139.6 | -18.54 | -10.12 | -18.29 | -51.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.